HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuya Kokabu Selected Research

Neoplasms (Cancer)

5/2023Computed tomography, magnetic resonance imaging, and positron emission tomography/computed tomography findings for the diagnosis of malignant struma ovarii: A case report.
4/2023Successful resection of growing teratoma syndrome in the abdominal wall with reconstruction using tensor fascia lata muscle flap: A case report and literature review.
10/2022Successful nedaplatin desensitization therapy in a patient with platinum-sensitive recurrent ovarian cancer: A case report and literature review.
8/2022Robot-assisted laparoscopic hysterectomy for early-stage endometrial cancer with massive uterine leiomyomas: A case report.
1/2022Genistein induces long-term expression of progesterone receptor regardless of estrogen receptor status and improves the prognosis of endometrial cancer patients.
4/2019Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
1/2019Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer.
5/2018Endometrioid carcinoma arising from diaphragmatic endometriosis treated with laparoscopy: A case report.
11/2016Primary osteosarcoma of the uterine corpus: A case report.
6/2016Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuya Kokabu Research Topics

Disease

10Neoplasms (Cancer)
05/2023 - 06/2016
5Endometrial Neoplasms (Endometrial Cancer)
08/2022 - 06/2016
2Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 02/2018
2Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 04/2019
2Endometriosis
01/2022 - 03/2019
1Struma Ovarii
05/2023
1Residual Neoplasm
04/2023
1Wounds and Injuries (Trauma)
04/2023
1Teratoma (Teratoid Tumor)
04/2023
1Carcinoma (Carcinomatosis)
10/2022
1Hypersensitivity (Allergy)
10/2022
1Morbid Obesity
08/2022
1Leiomyoma (Uterine Fibroids)
08/2022
1Body Weight (Weight, Body)
04/2019
1Retroperitoneal Fibrosis
04/2019
1Abdominal Pain (Pain, Abdominal)
04/2019
1Adenomyosis
05/2018
1Ascites
02/2018
1Neoplasm Metastasis (Metastasis)
11/2016
1Osteosarcoma (Osteogenic Sarcoma)
11/2016
1Postpartum Hemorrhage
10/2015
1Eclampsia
10/2015
1Disseminated Intravascular Coagulation
10/2015
1Pre-Eclampsia (Preeclampsia)
10/2015
1Abruptio Placentae (Placental Abruption)
10/2015
1Sepsis (Septicemia)
10/2015
1Hemolysis
10/2015
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
08/2014

Drug/Important Bio-Agent (IBA)

2PlatinumIBA
10/2022 - 02/2018
2Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 01/2022
2Estrogen ReceptorsIBA
01/2022 - 01/2019
2ERRalpha Estrogen-Related ReceptorIBA
01/2019 - 06/2016
1Colloids (Colloid)IBA
05/2023
1Fetal Proteins (Fetoprotein)IBA
04/2023
1Carboplatin (JM8)FDA LinkGeneric
10/2022
1nedaplatinIBA
10/2022
1Estrogen Receptor alphaIBA
01/2022
1GenisteinIBA
01/2022
1ProgesteroneFDA LinkGeneric
01/2022
1Forkhead Box Protein O1IBA
01/2022
1XCT790IBA
04/2019
1Zinc Finger E-box-Binding Homeobox 1IBA
01/2019
1VimentinIBA
01/2019
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2019
1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA
01/2019
1Transforming Growth Factor beta (TGF-beta)IBA
01/2019
1Paclitaxel (Taxol)FDA LinkGeneric
02/2018
1Bevacizumab (Avastin)FDA Link
02/2018
1Docetaxel (Taxotere)FDA Link
11/2016
1GemcitabineFDA Link
11/2016
1fibrin fragment D (D-dimer)IBA
10/2015
1Dacarbazine (DIC)FDA LinkGeneric
10/2015
1ThrombomodulinIBA
10/2015
1EnzymesIBA
10/2015
1Fibrinogen (Factor I)FDA Link
10/2015
1Prednisolone (Predate)FDA LinkGeneric
08/2014

Therapy/Procedure

3Drug Therapy (Chemotherapy)
04/2023 - 02/2018
2Therapeutics
10/2022 - 11/2016
2Hysterectomy
08/2022 - 05/2018
1Cystectomy
04/2023
1Adjuvant Chemotherapy
10/2022
1Operative Surgical Procedures
08/2022
1Robotic Surgical Procedures
08/2022
1Catheters
02/2022
1Brachytherapy
02/2022
1Radiotherapy
04/2019
1Intravenous Anesthesia
03/2019